Vitrexyl Tablet
FDA Label NDC 59088-164

Each caplet contains:

Vitamin A (as retinyl acetate)………………………….. 1500 mcg
Vitamin C (as ascorbic acid)……………………………… 120 mg
Vitamin D3 (as cholecalciferol)…………………………… 20 mcg
Vitamin E (dl-alpha tocopheryl acetate)…………………… 30 mg
Thiamin (as thiamine mononitrate)………………………… 3 mg
Riboflavin (vitamin B2)……………………………………. 3.4 mg
Niacin (as niacinamide)…………………………………… 20 mg
Vitamin B6 (as pyridoxine hydrochloride)…………………. 20 mg
Folate (as folic acid)……….. 1700 mcg DFE (1000 mcg folic acid)
Vitamin B12 (as cyanocobalamin)………………………….. 8 mcg
Calcium (as calcium carbonate)…………………………. 200 mg
Magnesium (as magnesium oxide)……………………… 200 mg
Zinc (as zinc oxide)……………………………………….. 25 mg
Selenium (as selenium amino acid chelate)………………. 55 mcg
Manganese (as manganese sulfate)……………………… 2.3 mg
Chromium (as chromium polynicotinate)……………….. 35 mcg
Molybdenum (as molybdenum amino acid chelate)……… 45 mcg

Other Ingredients:
BHT, dicalcium phosphate, organic cocoa
powder, croscarmellose sodium, crospovidone, magnesium
stearate, medium chain triglycerides, microcrystalline cellulose,
modified food starch, pork gelatin, starch aluminium octenyl
succinate, sodium ascorbate, sodium aluminum silicate, silicon
dioxide, stearic acid, sucrose, Clear Coating: (hydroxypropyl
methylcellulose, PEG-8).

Vitrexyl is indicated to provide vitamin supplement to men and women. Folic acid is effective in the treatment of megaloblastic anemias due to a deficiency of folic acid (as may be seen in tropical or nontropical sprue) and in anemias of nutritional origin, pregnancy, infancy, or childhood.

Vitrexyl is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Administration of folic acid alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient.

Folic acid in doses above 0.1 mg daily may obscure pernicious anemia, in that
hematologic remission can occur while neurological manifestations remain
progressive.
There is a potential danger in administering folic acid to patients with undiagnosed
anemia, since folic acid may obscure the diagnosis of pernicious anemia by
alleviating the hematologic manifestations of the disease while allowing the
neurologic complications to progress. This may result in severe nervous system
damage before the correct diagnosis is made. Adequate doses of vitamin B12 may
prevent, halt, or improve the neurologic changes caused by pernicious anemia.
The patient’s medical conditions and consumption of other drugs, herbs, and/or
supplements should be considered.

For use on the order of a healthcare practitioner.
Call your doctor about side effects. To report side effects, call PureTek Corporation
at 1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Vitrexyl is not recommended for and should not be given to patients receiving
levodopa because the action of levodopa is antagonized by pyridoxine. There is a
possibility of increased bleeding due to pyridoxine interaction with anticoagulants
(e.g., Aspirin, Heparin or Clopidogrel).

Allergic sensitization has been reported following both oral and parenteral
administration of folic acid.
Adverse reactions have been reported with specific vitamins and minerals but
generally at levels substantially higher than those contained herein. However,
allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the
usual recommended levels, has been associated with gastrointestinal intolerance in
some patients.

One (1) Vitrexyl caplet daily, between meals or as directed by a physician. Do not administer to children under the age of 12.

Vitrexyl are yellow to brown speckled, oblong, coated caplets with "PT A16" debossed horizontally on
one side, bottles containing 30 caplets – NDC 59088-164-54. Dispense in a tight,
light-resistant container as defined in the USP/NF with a child resistant closure.

Store at controlled room temperature 20°-25°C (68°-77°F). [See USP]. Protect from
light and moisture and avoid excessive heat.

Do not use if bottle seal is broken.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
Store at controlled room temperature 20°-25°C (68°-77°F). [See USP].
Protect from light and moisture and avoid excessive heat.
To report a serious adverse event or to obtain product information, contact
877-921-7873.

Manufactured in the USA by:

PureTek Corporation
Panorama City, CA 91402
Questions? Call toll-free:
1-877-921-7873

List No: 16454 JPA Rev: 36960